Latest On-Demand Webinars & Online Events

To adequately assess the safety and efficacy of candidate gene therapies, robust bioanalytical technologies must support regulated studies. Hence, many labs now incorporate the latest qPCR and digital PCR (dPCR) methods into their preclinical and clinical development workflows to assure data accuracy and product effectiveness.

Liquid biopsies and the advent of blood-based diagnostics have emerged in recent years as promising alternatives and complements to tissue-based genomic and proteomic assays. Biodesix, a global leader in molecular diagnostics and assay design/development, leverages cutting-edge technology, including droplet digital PCR (ddPCR), to advance translational and clinical oncology research and to assist biopharma companies in delivering new, targeted, life-saving therapies to patients.

This presentation provides a comprehensive exploration of new blood-based diagnostics, including the development of a microsatellite instability (MSI) test on the ddPCR platform and the dynamic monitoring capabilities of ddPCR using circulating tumor DNA (ctDNA).

This webinar highlights the latest affinity chromatography solutions for the quick and easy purification of multiple AAV serotypes across a variety of column setups.

This webinar highlights the latest ways to maximize productivity in your AAV manufacturing workflow using affinity chromatography methods.

Demonstrating viral clearance is essential to the downstream processing of certain drugs. However, due to the specialized nature of this quality control step, services are often outsourced contributing to higher workflow costs and slower turnaround times.

Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this continue to develop in the next five years?
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.

The third edition of this online symposium will provide industry and academic scientists with the opportunity to hear from experts from across the field. Focus will be given to the safety, authenticity and quality of food and beverages as well as the future of food products such as meat substitutes and alternative proteins.

The global market for antibody therapeutics is rising rapidly and newer, engineered modalities such as bi-specific antibodies and antibody fragments are entering clinical studies in record numbers.

In the webinar, we discuss a suite of metabolic stability assays developed using an AEMS system.

This exclusive AMA event grants you unprecedented access to the pioneering expert Prof. Michael Snyder a distinguished professor at Stanford University known for his ground-breaking work in digitalizing scientific research in the genomics and personalized medicine field.